Influenza vaccination in healthcare professionals

BMJ ◽  
2012 ◽  
Vol 344 (mar28 1) ◽  
pp. e2217-e2217 ◽  
Author(s):  
H. Nair ◽  
A. Holmes ◽  
I. Rudan ◽  
J. Car
2019 ◽  
Vol 21 (12) ◽  
pp. 676-681
Author(s):  
Andrea King ◽  
Tracy Doherty ◽  
Keith Ian Quintyne ◽  
Elaine Brabazon

Flu season has arrived, and with it comes the increased risk of health professionals infecting those under their care. It is vital, therefore, that barriers that may deter healthcare professionals from being vaccinated are addressed. Researchers at Ireland's Department of Public Health presents its fascinating findings about these obstacles and how to overcome them


2016 ◽  
Vol 21 (3) ◽  
pp. 129
Author(s):  
Sue McFarlane ◽  
Aurea Ayalon ◽  
Terri Cripps ◽  
Margaret Evans ◽  
Susan Jain ◽  
...  

2021 ◽  
Vol 16 (4) ◽  
pp. 205-214
Author(s):  
Trang Thi Thu Nguyen ◽  
Vijj Kasemsup ◽  
Sariyamon Tiraphat ◽  
Samrit Srithamrongsawat ◽  
Nalinee Nakittipha Chuakhamfoo

Background: While Vietnam’s Expanded Program on Immunization does not cover influenza vaccines, people must pay out-of-pocket for influenza vaccination. Healthcare professionals have a high risk of contracting influenza, but their vaccination rate is low.  Objective: To examine the willingness to pay (WTP) for influenza vaccination among healthcare professionals in Vietnam. It also recommends financing sources for influenza vaccination among healthcare professionals and determines possible measures to expand vaccine coverage. Method: We interviewed 130 healthcare professionals in a national hospital in Hanoi in July 2021. We used Andersen’s behavioral Model (ABM) as an initial approach. The double-bounded dichotomous-choice questions were used to determine WTP for influenza vaccination among the target group. Collected responses were coded and analysed through IBM SPSS version 20 for descriptive, chi-square analyses.  Results: Most of the healthcare professionals who responded to this study were female with 75.4 % of the total 130 respondents. The mean age of participants was 34.08 years old. The average maximum WTP for influenza vaccination services was 357.57 VND (USD 15.3). Most of the participants reported that individuals should pay a part of the cost, and four-fifths reported they believed that the government and medical insurance should subsidize the service (80.8 % and 85.4 %). The Chi-square test showed that there was a significant association between perceived severity and history of influenza vaccination with the WTP, X2(1, N=130) = 4.18, p = 0.04 and X2 (1, N=130) = 7.81, p = 0.005, respectively. Conclusion: The WTP for influenza vaccination among healthcare professionals was found relatively high. Suggesting that price is not a primary barrier. The government and medical insurance were believed to be the potential agencies for improving vaccination uptake as these agencies were expected to be the subsidized actors. Other health interventions such as influenza literacy and communication methods are also needed to expand vaccine coverage. (*The paper was presented at The Hong Kong Polytechnic University’s College of Professional and Continuing Education (CPCE) Conference “Post-pandemic health and long-term care: A new paradigm”. September 2021)


Vaccine ◽  
2016 ◽  
Vol 34 (11) ◽  
pp. 1393-1398 ◽  
Author(s):  
Tahir Mehmood Khan ◽  
Aziz Ullah Khan ◽  
Iftikhar Ali ◽  
David Bin-Chia Wu

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Simon Oakley ◽  
Julien Bouchet ◽  
Paul Costello ◽  
James Parker

Abstract Background In the UK, annual influenza vaccination is currently recommended for adults aged 16–64 years who are in a clinical at-risk group. Despite recommendations, rates of vaccine uptake in the UK have historically been low and below national and international targets. This study aims to analyse vaccine uptake among adults in clinical at-risk groups from the 2015–2016 influenza season to the present. Methods A retrospective analysis of influenza vaccine coverage in the UK was conducted using data extracted from publicly available sources. Clinically at-risk individuals (as defined by Public Health England), including pregnant women, aged 16–64 years, were included in this study. Results Influenza vaccination coverage rates across the UK in adults aged 16–64 years in a clinical at-risk group have been consistently low over the past 5 years, with only 48.0, 42.4, 44.1 and 52.4% of eligible patients in England, Scotland, Wales and Northern Ireland receiving their annual influenza vaccination during the 2018–2019 influenza season. Influenza vaccine coverage was lowest in patients with morbid obesity and highest in patients with diabetes in 2018–2019. Coverage rates were below current national ambitions of ≥75% in all clinical risk groups. In these clinical at-risk groups, influenza vaccine coverage decreased between 2015 and 2019, and there was considerable regional variation. Conclusions Uptake of the influenza vaccine by adults aged 16–64 years in a clinical at-risk group was substantially below the national ambitions. As a result, many individuals in the UK remain at high risk of developing severe influenza or complications. Given that people who are vulnerable to COVID-19 are also at increased risk of complications from influenza, during the 2020–2021 season, there is a heightened need for healthcare professionals across the UK to address suboptimal vaccine uptake, particularly in at-risk patients. Healthcare professionals and policymakers should consider measures targeted at increasing access to and awareness of the clinical benefits of the influenza vaccine.


Sign in / Sign up

Export Citation Format

Share Document